主题演讲

Stephen Fesik

Targeting Ras and MYC for the Treatment of Cancer

Stephen Fesik, Ph.D.

Professor of Biochemistry, Pharmacology, and Chemistry, Orrin H. Ingram II Chair in Cancer Research, Vanderbilt University School of Medicine

Craig Crews

以活性为基础的蛋白质体学:全球规模的蛋白质与配体之发现

Benjamin F. Cravatt, Ph.D.

Professor and Co-Chair, Department of Molecular Medicine, The Scripps Research Institute


Cambridge Healthtech Institute主办的13th Annual Drug Discovery Chemistry(第13届药物开发化学年会)是以药厂及生技企业等医药化学领域研究开发专家为对象的热闹年会。 本年会焦点围绕在小分子候补药物的开发与改良相关课题,不但准备了许多有趣的会议内容,与会人士也可依其感兴趣的主题自由安排丰富的客制化议程。 2018年的会议拓展了「Small Molecules for Cancer Immunotherapy(癌症免疫疗法的小分子药物)」范畴,新增「Ubiquitin Proteasome System Inhibitors(泛素-蛋白酶体系统抑制剂)」、「Targeting Complex Membrane Proteins(复杂的膜蛋白质标的化)」、「Lead Optimization for Drug Safety(以提升药物安全性为目的之先导化合物最佳化)」等主题。

Event Features

  • More than 150 presentations
  • 750+ high-level participants
  • 70+ posters
  • Interactive roundtable, breakout & panel discussions
  • "Track-hop" between concurrent meetings
  • Exclusive exhibit & poster viewing hours
  • Dedicated networking opportunities

Short Courses

Maximize your educational and networking opportunities while in San Diego by adding on one or more interactive short courses!